postmenopausal women

Study: Clinical trials indicate positive results for Zika vaccineThree Phase 1 human clinical trials evaluating the efficacy of an Army-developed Zika purified inactivated virus (ZPIV) vaccine have shown it to be safe and well tolerated, according to a recent study. Plus: Another study has found an association between postmenopausal vasomotor symptoms (VMS), including hot flashes and night sweats, and elevated risk of diabetes.
Is genetic testing for cancer survivors underutilized?One study looks at whether or not women with histories of breast or ovarian cancer are receiving necessary genetic testing. Plus: Can in-office hysteroscopy reliably evaluate uterine pathology? Also, researchers say mammographic density changes should be monitored in patients undergoing hormone therapy as a possible indicator of breast cancer.
Combination pack approved for breast cancer treatmentFDA approves ribociclib plus letrozole to treat a subset of advanced breast cancer patients.
Breast cancer drug research roundup from ASCOAmong the many poster sessions being presented at the 2015 American Society of Clinical Oncology (ASCO) annual meeting in Chicago, IL, are several on the latest trials that are planned to evaluate potential treatment options for breast cancer. These trials include 1 phase 2 study and 3 phase 3 studies.
FDA approves Ibrance to treat metastatic breast cancerIbrance is a potent and selective inhibitor of cyclin-dependent kinases (CDKs) 4 and 6, which complex with a regulatory protein, called cyclin, to control cancer cell cycling. The FDA has approved it for use in the treatment of metastatic breast cancer.
NSAID use can reduce breast cancer recurrence in overweight, obese womenOverweight and obese postmenopausal breast cancer patients taking aromatase inhibitors may gain a significant benefit by adding nonsteroidal anti-inflammatory drugs (NSAIDs) to their treatment, according to a study published in the August 14 issue of Cancer Research.
Sedentary lifestyle increases mortality riskThe less a postmenopausal woman moves, the higher her risk of mortality, according to a new study in the American Journal of Preventive Medicine.
Sugary beverages linked to endometrial cancerDrinking sugar-sweetened beverages boosts calories—and also risk of estrogen-dependent type 1 endometrial cancer—according to a study of more than 23,000 postmenopausal women. Published in Cancer Epidemiology, Biomarkers & Prevention, the report found no similar link with sugar-free drinks.
A little exercise better than none for overweight postmenopausal women
A little exercise better than none for overweight postmenopausal womenWomen should not feel that they need to log long hours of vigorous exercise to see any benefits, says a study from Spain.